• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Open Access Portal
  • Customer Community
CareSelect

CareSelect

Eliminate Waste and Control Costs

  • CareSelect® Imaging
  • CareSelect® Lab

Imaging

A PAMA Consultation

October 20, 2016 By Bob Cooke

When we start the conversation about imaging decision support one topic always jumps to the forefront – “PAMA”. The sections of 2017 MPFS proposed rule that relate to the implementation of decision support for compliance with the Protecting Access to Medicare Act of 2014 (PAMA) have a lot of nuances. From what we’ve heard out in the market, interpreting these nuances can be a daunting and confusing task.

pama-blog-imageWhat We Know

When diving in to the CMS proposed rule, four basics for PAMA compliant CDS implementation appear to be clear:

  • The proposed rule mandates that a compliant decision support solution must start reporting by January 1st, 2018.
  • Every imaging order placed must consult (e.g. ask a question of) a Clinical Decision Support Mechanism (CDSM) that leverages Appropriate Use Criteria (AUC) published by one or more qualified Provider Led Entities (qPLE).
  • At a minimum a CMS qualified CDSM must return one of at least three answers:
    • Complies with an Appropriate Use Criteria (AUC)
    • Does Not comply with an AUC
    • No Applicable AUC Available
  • Priority Clinical Areas (PCA) will be used by CMS to “identify outlier ordering professionals”. PCA are a list of broadly defined clinical conditions, E.g.: abdominal pain, that create a measurement baseline by defining “required” AUC coverage for a CDSM. Today, PCA cover clinical scenarios indicated for approximately 40% of all high cost exam orders. PCA will expand to cover more clinical scenarios each year.

What We Don’t

The access and claims reporting requirements remain undefined. These processes are part of the future rule-making process and will not be addressed in the final rule due out this November. Two main requirements remain unclear:

  • The reporting requirements, including how to submit claims in order to ensure compliance is “measured”, at least minimally linked to the PCA, and ideally ensure that the program “works”.
  • The algorithm by which providers will be defined as “outliers” and the additional authorization hurdles that they will be subject to.

A Real World PAMA consultation

In the real world, a PAMA consultation is an order placed in the EMR for Medicare Part B advanced imaging.

During the ordering process the user asks the CDSM a “question” via a structured, coded indication or reason for exam.

To comply with PAMA, the CDSM must reference AUC and return an answer of ‘Complies’, ‘Does Not Comply’ or ‘No AUC Apply’. It is important to note that the CDSM must respond for every exam ordered.

Priority Clinical Areas

PCAs do one thing – define areas for provider measurement. It can be tempting to think that your organization might get away with a solution that only covers the PCAs with a supposedly simpler CDSM interaction. This however is not the case.

By limiting CDSM AUC coverage to only select clinical areas, PCAs only constrain the number of useful responses a CDSM can provide. The answer of ‘No AUC Apply’ does not ensure the correct order is being placed, merely that the system “Does Not Know”. Additionally, as PCAs define outlier measurement, the ordering user needs to know if an AUC applies (is within a PCA) for the indication they are placing the order for to avoid becoming an outlier.

When other CDSM developers talk about AUC, it is critical to understand that there is a lot of catch up that non-medical society qPLEs have to do to “re-invent the wheel.” This can lead to significant gaps in coverage and a high percentage of ‘No AUC Apply’ answers. CareSelect Imaging leverages AUC from all qPLE medical societies. These societies have invested tens of thousands of hours to develop evidence-based AUC that help doctors use the right imaging test to answer their clinical question.

As these clinical questions (a specific description of the patient condition) are the best way to get an answer through imaging (the most appropriate imaging test), you can imagine that providers seek both specificity and coverage. PCAs really don’t limit the questions in any way especially as the claims process is as yet unknown. A complete payable claim requires both evidence of CDSM consultation and to be coded with enough clinical specificity to ensure that outlier status is avoided. When AUC coverage is limited only to the scope defined by the PCAs this becomes impossible.

Beyond Compliance

A specific clinical question transcends compliance. A clear, concise indication informs the ordering, protocoling and interpretation of imaging and results in less re-work for furnishing services.1 When a CDSM, like CareSelect Imaging, allows you to properly frame questions and gives useful answers, interaction becomes routine and helpful vs. punitive and “fatiguing”. This enables the CDSM to provide useful guidance to the user for every imaging order.

A shorter list of “questions”, organized around the PCA, would force the provider to ask questions that will ensure the “right answer”. This effectively creates an environment where providers game the system, and the furnishing site is forced to verify the question truly matches to the answer to ensure there is a valid, payable claim.

Next Steps

Based on our analysis of the published claims data in the proposed rule, the 8 clinical areas in the proposed rule still cover well over 450 clinical indications, ranging from diagnostic to cancer and cardiac imaging.

The known claims data, released by CMS2, indicates that far more than 8 questions will be necessary, with a further expansion in next year’s rule. If you limit the questions, you will end up with an incomplete system and the answers and evidence will not be clear enough to generate a payable claim (aka comply).

So then, does the rulemaking cycle even matter when deciding how to implement? Whether it is 8 or 80 priority clinical areas, we already know what we need to know about implementation of the provider side and how to prepare for compliance on the claims side: comprehensive coverage.

Every single day another health system adopts our imaging solutions or brings our solutions online within their EMR. Over the last 12 months, we have provided over 20 million AUC consultations at over 1000 acute care facilities with over 100,000 physicians accessing our solution. We know how to do this.

Consult with your EMR vendor about implementing PAMA compliant imaging decision support with ACR Select or our CareSelect Imaging solution. In this case, the answer is clear.

  1. Rockford Health System, “HIMMS Analytics Stage 7 Case Study,” http://www.himssanalytics.org/system/files_force/Rockford%20Health.pdf?download=1
  1. “Data Analysis – Centers for Medicare and Medicaid Services,” https://www.cms.gov/Medicare/Quality-Initiatives-Patient-Assessment-Instruments/Appropriate-Use-Criteria-Program/data.html

Filed Under: Blog, Legislation, PAMA Tagged With: AUC, CDSM, CMS, Decision Support, Imaging, PAMA

National Decision Support Company to debut CareSelect Imaging at RSNA 2016

October 12, 2016 By National Decision Support Company

Expanded imaging platform features multiple Appropriate Use Criteria sources and enhanced decision support capabilities

Madison, WI (October 11, 2016) – At RSNA 2016 National Decision Support Company will showcase its expanded imaging decision support solution, CareSelect Imaging. Since the announcement of its flagship ACR Select solution in 2012 NDSC has earned the trust of prestigious healthcare providers and content sources worldwide. CareSelect Imaging expands on the range of criteria offered for imaging decision support and adds new core capabilities to the delivery platform.

“Through CareSelect Imaging, NDSC clients can now immediately access a comprehensive range of Appropriate Use Criteria (AUC) published by every medical specialty society and multiple provider led entities qualified by CMS to produce criteria as outlined in the provisions of the Protecting Access to Medicare Act of 2014 (PAMA),” said Bob Cooke, VP of Marketing, NDSC.

The expanded AUC and indications from multiple qPLE cover comprehensive clinical scenarios for diagnostic, cardiac and cancer imaging through a single delivery platform. CareSelect imaging now contains Pediatric AUC and indications published in a joint effort by the Society of Pediatric Radiology and American College of Radiology. These new Pediatric criteria build on the foundational criteria sets in NDSC’s flagship ACR Select offering as well as criteria from the American College of Cardiology and the National Comprehensive Cancer Network and other medical specialty societies.

“Delivering a comprehensive set of criteria and indications all rationalized into a single delivery platform assures providers that CareSelect Imaging will enable full compliance with all aspects of PAMA,” Cooke said. “On the delivery side, this assures that providers find the correct clinical question to answer through imaging to avoid outlier status with enough clinical specificity to ensure correct coding for a payable claim for the Radiologist. This unified set of criteria also enables sites to readily adapt or create new guidelines to suit local practice or payer requirements.”

Annotated Decision Support
New Annotated Decision Support Functionality

CareSelect Imaging includes a sophisticated calculation engine powered by a rich exchange of data with the EMR. The calculation engine enables new capabilities including the computation of Wells and PERC scores for Pulmonary Embolism and Pediatric Head Trauma based on PECARN (in support of JACHO requirements) and the ability to further inform provider feedback with data such as lab values and pregnancy status when accessing AUC.

“ACR Select remains the foundation of our imaging solution and still represents the majority of the decision support criteria,” Cooke Said. “CareSelect Imaging expands our imaging solution to offer a community of qualified and respected criteria, delivered through a platform that informs the order entry process and provides an automated exchange of authorization data with payers.”

The CareSelect platform is fully embedded within the order entry systems of all leading EMR platforms.

More Information about CareSelect Imaging is available at nationaldecisionsupport.com/imaging
Come visit with NDSC at CHC 2016 or RSNA 2016

# # #

About National Decision Support Company

National Decision Support Company provides enterprise wide Clinical Decision Support solutions that enable more efficient and appropriate care, improve population health, and save money. Our CareSelect technology platform converts published guidelines from credible, compliant content sources into actionable decision support criteria delivered directly into the EMR workflow.

About CareSelect Imaging

CareSelect Imaging expands on the ACR Select Technology Platform to deliver a comprehensive range of Appropriate Use Criteria for diagnostic imaging. AUC is sourced from qualified Provider Led Entities (qPLE) including the American College of Radiology, the American College of Cardiology and the National Comprehensive Cancer Network®. Criteria is delivered directly into the EMR workflow to provide actionable, PAMA compliant decision support in real time.

Media Contact:

Bob Cooke –  VP of Marketing, NDSC
rcooke@nationaldecisionsupport.com
203.918.5085

Filed Under: News & Insights Tagged With: CareSelect, CDS, Imaging, PAMA, RSNA

Primary Sidebar